Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

Q32 Bio Inc. , ("Q32 Bio") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other autoimmune and inflammatory diseases, today announced the ...

Q32 Bio Inc. , ("Q32 Bio") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today announced ...

Harlan Robins liquidated 386,240 shares under a pre-scheduled Rule 10b5-1 trading plan, retaining over 1 million shares worth ...

There is a quiet crisis unfolding in boardrooms and government offices alike. It is not a crisis of resources, talent, or ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, ...

The 2025 Audi SQ5 continues Audi's tradition of building high-performance SUVs that excel in everyday driving. Powered by a 3 ...

UCSF has launched the Alzheimer's Tau Platform (ATP) trial, the first large-scale clinical trial testing combination therapies that target both amyloid plaques and tau tangles simultaneously.

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today announced the grant of a new patent (number 12,673,088) entitled ...

A comprehensive review led by Professors Malgorzata Kloc and Xian Chang Li at the Immunobiology and Transplant Science Center ...

The human respiratory system, extending from the nasal cavity to the lungs, harbors diverse microbial communities composed of ...

Genomic analysis of ancient and modern human DNA has exposed a striking pattern in how Neanderthal genes entered the human ...